Literature DB >> 8064230

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis.

M Detmar1, L F Brown, K P Claffey, K T Yeo, O Kocher, R W Jackman, B Berse, H F Dvorak.   

Abstract

Psoriatic skin is characterized by microvascular hyperpermeability and angioproliferation, but the mechanisms responsible are unknown. We report here that the hyperplastic epidermis of psoriatic skin expresses strikingly increased amounts of vascular permeability factor (VPF; vascular endothelial growth factor), a selective endothelial cell mitogen that enhances microvascular permeability. Moreover, two VPF receptors, kdr and flt-1, are overexpressed by papillary dermal microvascular endothelial cells. Transforming growth factor alpha (TGF-alpha), a cytokine that is also overexpressed in psoriatic epidermis, induced VPF gene expression by cultured epidermal keratinocytes. VPF secreted by TGF-alpha-stimulated keratinocytes was bioactive, as demonstrated by its mitogenic effect on dermal microvascular endothelial cells in vitro. Together, these findings suggest that TGF-alpha regulates VPF expression in psoriasis by an autocrine mechanism, leading to vascular hyperpermeability and angiogenesis. Similar mechanisms may operate in tumors and in healing skin wounds which also commonly express both VPF and TGF-alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8064230      PMCID: PMC2191647          DOI: 10.1084/jem.180.3.1141

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Carbonic anhydrase--a marker for fenestrated capillaries in psoriasis.

Authors:  W Jungkunz; M Eichhorn; J Wörl; W C Marsch; H Holzmann
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  The primary histologic lesion of seborrheic dermatitis and psoriasis.

Authors:  H Pinkus; A H Mehregan
Journal:  J Invest Dermatol       Date:  1966-01       Impact factor: 8.551

3.  In situ hybridization analysis of cytokine, proto-oncogene and tumour suppressor gene expression in psoriasis.

Authors:  P Schmid; D Cox; G K McMaster; P Itin
Journal:  Arch Dermatol Res       Date:  1993       Impact factor: 3.017

4.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; D R Senger; H F Dvorak
Journal:  Cancer Res       Date:  1993-10-01       Impact factor: 12.701

5.  Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas.

Authors:  L F Brown; B Berse; R W Jackman; K Tognazzi; E J Manseau; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1993-11       Impact factor: 4.307

6.  Human keratinocytes are a major source of cutaneous platelet-derived growth factor.

Authors:  J C Ansel; J P Tiesman; J E Olerud; J G Krueger; J F Krane; D C Tara; G D Shipley; D Gilbertson; M L Usui; C E Hart
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

7.  Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.

Authors:  R A Berkman; M J Merrill; W C Reinhold; W T Monacci; A Saxena; W C Clark; J T Robertson; I U Ali; E H Oldfield
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

Review 8.  Vascular permeability factor (VPF, VEGF) in tumor biology.

Authors:  D R Senger; L Van de Water; L F Brown; J A Nagy; K T Yeo; T K Yeo; B Berse; R W Jackman; A M Dvorak; H F Dvorak
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

9.  Vascular permeability factor (vascular endothelial growth factor) in guinea pig and human tumor and inflammatory effusions.

Authors:  K T Yeo; H H Wang; J A Nagy; T M Sioussat; S R Ledbetter; A J Hoogewerf; Y Zhou; E M Masse; D R Senger; H F Dvorak
Journal:  Cancer Res       Date:  1993-06-15       Impact factor: 12.701

10.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing.

Authors:  L F Brown; K T Yeo; B Berse; T K Yeo; D R Senger; H F Dvorak; L van de Water
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more
  142 in total

Review 1.  Influence of host microvascular environment on tumour vascular endothelium.

Authors:  M Kubitza; L Hickey; W G Roberts
Journal:  Int J Exp Pathol       Date:  1999-02       Impact factor: 1.925

2.  VEGF expression by epithelial and stromal cell compartments: resolving a controversy.

Authors:  D R Senger; L Van De Water
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

3.  Antibody-mediated delivery of VEGF-C potently reduces chronic skin inflammation.

Authors:  Simon Schwager; Silvana Renner; Teresa Hemmerle; Sinem Karaman; Steven T Proulx; Roman Fetz; Alexandra Michaela Golding-Ochsenbein; Philipp Probst; Cornelia Halin; Dario Neri; Michael Detmar
Journal:  JCI Insight       Date:  2018-12-06

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

5.  Vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in normal and atherosclerotic human arteries.

Authors:  T Couffinhal; M Kearney; B Witzenbichler; D Chen; T Murohara; D W Losordo; J Symes; J M Isner
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 6.  Molecular targeting of angiogenesis for imaging and therapy.

Authors:  Simon S Brack; Ludger M Dinkelborg; Dario Neri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-08-05       Impact factor: 9.236

Review 7.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

8.  Expression of Angiogenic Factors in Psoriasis Vulgaris.

Authors:  Lakshna Sankar; Dhanalakshmi Arumugam; Sudha Boj; Priyanka Pradeep
Journal:  J Clin Diagn Res       Date:  2017-03-01

9.  Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine.

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Stella Douma; Areti Triantafyllou
Journal:  Clin Rheumatol       Date:  2007-11-10       Impact factor: 2.980

Review 10.  Regulation of microvascular permeability by vascular endothelial growth factors.

Authors:  D O Bates; N J Hillman; B Williams; C R Neal; T M Pocock
Journal:  J Anat       Date:  2002-06       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.